1,002
Participants
Start Date
December 29, 2020
Primary Completion Date
September 30, 2027
Study Completion Date
December 31, 2027
New York Oncology Hematology, P.C., Albany
Maryland Oncology Hematology, P.A., Silver Spring
Virginia Cancer Specialists, PC, Fairfax
Virginia Oncology Associates, Newport News
Woodlands Medical Specialists, PA, Pensacola
Southern Cancer Center, PC, Daphne
Oncology Hematology Care Clinical Trials, LLC, Cincinnati
Minnesota Oncology Hematology, P.A., Minneapolis
Illinois Cancer Specialists, Niles
Texas Oncology-Dallas Presbyterian Hospital, Dallas
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology- Northeast Texas, Tyler
Texas Oncology- DFWW, Arlington
Texas Oncology - Fort Worth Cancer Center, Fort Worth
Texas Oncology-McAllen, McAllen
Texas Oncology - West Texas, Abilene
Rocky Mountain Cancer Center, Denver
Willamette Valley Cancer Institute and Research Center, Eugene
US Oncology Research
INDUSTRY